Physician profile
Daniel Lax
NPI 1205254075
$3,278.71
in general payments reported to CMS, 2019-2025
23 companies · $45.95 in 2025
The $45.95 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $343 · 2021: $365 · 2022: $1,903 · 2023: $355 · 2024: $59.59 · 2025: $45.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,054.94 | 2022 | |
| Abbvie INC. | $829.49 | 2019-2025 | |
| Boston Scientific Corporation | $289.42 | 2021-2022 | |
| Exeltis, USA INC. | $209.36 | 2021-2024 | |
| Pfizer INC. | $185.11 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $77.55 | 2021-2022 | |
| Applied Medical Resources Corporation | $69.22 | 2020 | |
| Merck Sharp & Dohme LLC | $66.07 | 2020-2023 | Gardasil 9 |
| Sumitomo Pharma America, INC. | $65.78 | 2023 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $59.99 | 2020-2025 | |
| Exact Sciences Corporation | $49.92 | 2023 | Cologuard Collection Kit |
| Myovant Sciences INC. | $46.03 | 2022 | |
| Evofem Biosciences, INC. | $44.57 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $43.54 | 2020 | |
| Coopersurgical, INC. | $40.36 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $30.54 | 2019 | |
| Mission Pharmacal Company | $21.41 | 2021 | |
| Therapeuticsmd, INC. | $20.98 | 2020 | |
| Urovant Sciences INC | $18.29 | 2022 | |
| Amgen INC. | $17.25 | 2019 | |
| Monaghan Medical Corporation | $13.31 | 2023 | Aerobika |
| Astellas Pharma US INC | $13.00 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.